Health and Medicine

October 2, 2012

VU study shows no gender gap in sports concussions

A new study conducted to review symptoms and neurocognitive findings in male and female high school soccer players revealed no gender-related differences.

By VUMC News and Communications
September 27, 2012

Study ties early menopause to heart attack, stroke

Women who experience early menopause are more likely to have a heart attack or stroke than women whose menopause occurs at a later age, according to a new study by Melissa Wellons, M.D., assistant professor of Medicine in the Vanderbilt Division of Diabetes, Endocrinology and Metabolism.

By Craig Boerner
September 27, 2012

Grants help propel glaucoma, macular degeneration research

Three Vanderbilt University Medical Center faculty members have been awarded grants from the American Health Assistance Foundation to support their research on glaucoma and macular degeneration — the two leading causes of irreversible blindness in the world.

By Jessica Pasley
September 27, 2012

Target acquired for aggressive tumor

New therapeutic target for angiosarcoma – an aggressive, highly fatal tumor of the blood vessels – identified.

By VUMC News and Communications
September 25, 2012

Cell entry ports for cold virus

The respiratory virus HMPV uses its fusion (F) protein – which interacts with cellular receptors called integrins – to bind to and enter target cells.

By Leigh MacMillan
puzzel pieces, autism
September 24, 2012

Little evidence supports medical treatment options for adolescents with autism

Despite studies that show that many adolescents and young adults with autism spectrum disorders are being prescribed medications, there is almost no evidence to show whether these medications are helpful in this population.

By VUMC News and Communications
September 21, 2012

VU, Bristol-Myers to collaborate on Parkinson’s therapies

Vanderbilt University and Bristol-Myers Squibb have signed a collaboration agreement for the discovery, development and commercialization of novel therapies acting on the mGluR4 glutamate receptor, known as positive allosteric modulators, or PAMs, for the treatment of Parkinson’s disease.
By Bill Snyder
September 21, 2012

HER2 may impact lung cancer therapy

A protein associated with aggressive breast cancers may also influence resistance of lung cancer to targeted therapies.
By VUMC News and Communications
September 20, 2012

Grant renewal boosts GI cancer research program

Vanderbilt-Ingram Cancer Center’s gastrointestinal Specialized Program of Research Excellence (SPORE) has been awarded its third round of funding by the National Cancer Institute (NCI).
By VUMC News and Communications
September 19, 2012

How ‘Jedi’ disposes of dead neurons

The protein Syk is essential for clearing away neuron “corpses” in the developing peripheral nervous system.
By Leigh MacMillan
September 13, 2012

Study tracks potential coverage gaps under Affordable Care Act

An analysis of Massachusetts’ health care reform program by a Vanderbilt researcher indicates insurance gaps may remain as the Affordable Care Act (ACA) expands insurance coverage beginning in 2014.
By VUMC News and Communications
September 13, 2012

Cells with LIP eat their neighbors

A transcription factor called LIP is capable of causing one cell to consume another.
By Leigh MacMillan
September 11, 2012

Enzyme counters stomach acid attack

Dysfunction or loss of an “antioxidant” enzyme may lead to higher risk for esophageal cancer in patients with gastric reflux disease.
By VUMC News and Communications
1 … 165 166 167 168 169 … 197